The Valley Desk

NCT00861744 · Interventional trial

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Overall registry status Completed

Phase 2

Conditions Measles, Measles-Mumps-Rubella Vaccine, Mumps, Rubella

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov